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Abstract
Background: Although Indonesia has high fatality rate of human A/H5N1 cases, epidemiological and clinical data
on influenza virus circulation among humans has been limited. Within Indonesia, Bali province is of interest due to
high population densities of humans, pigs and poultry. This study aims to characterize and compare the
epidemiological and clinical patterns of influenza viruses in humans through surveillance among patients with
influenza-like illness (ILI) in Bali, Indonesia.
Methods: ILI patients were recruited at 21 sentinel health facilities across all nine regencies in Bali, from July 2010
to June 2014. PCR-based assays were used for detection and subtyping of influenza viruses. Demographic,
behavioural and clinical data were tested for associations with influenza using chi-squared tests and logistic
regression.
Results: Of 2077 ILI patients, 291 (14.0%) tested positive for influenza A, 152 (7.3%) for influenza B, and 16 (0.77%)
for both influenza A and B. Of the influenza A isolates, the majority 61.2% were A/H3N2, followed by A/H1N1-pdm09
(80; 26.1%). Two A/H5N1 were identified. Influenza positive rates were significantly higher during wet season months
(28.3%), compared with the dry season (13.8%; χ2 = 61.1; df = 1; p < 0.0001). Clinical predictors for infection varied by
virus type, with measured fever (≥38 °C) more strongly associated with influenza B (AOR: 1.62; 95% CI: 1.10, 2.39).
Conclusion: Influenza circulates year-round among humans in Bali with higher activity during the wet season. High
contact rates with poultry and pigs, along with influenza virus detection that could not be subtyped through
conventional assays, highlight the need for molecular studies to characterize epidemiological and evolutionary
dynamics of influenza in this setting.
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Background
The Asia-Pacific region plays a key role in the emer-
gence of novel influenza viruses, as well as global trans-
mission of seasonal influenza viruses [1, 2]. Indonesia,
the largest nation in Southeast Asia, is of particular
importance for influenza surveillance, as it is endemic
for highly pathogenic avian influenza A/H5N1 in birds
[3–5], and has the second highest cumulative number
of reported human cases H5N1 worldwide. Since 2003
until April 2016, there were 199 confirmed human
H5N1 cases recorded in Indonesia, with a case fatality
rate among the highest globally at 83% [6]. Further-
more, H5N1 has also crossed the species barrier into
pigs in Indonesia [7–9]. This is of concern, as pigs may
act as a “mixing vessel” for avian, swine and human in-
fluenza viruses and serve as a source for the emergence
of novel reassortant viruses, since the trachea of pigs
contains receptors for both avian and human influenza
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viruses [10]. Such concerns were elevated with the emer-
gence of a new influenza A virus (A/H1N1-pdm09) in
2009 which caused our most recent pandemic, with fears
that this strain could genetically re-assort with other influ-
enza viruses, such as H5N1, to generate a new pandemic
strain of higher pathogenicity.
Within Indonesia, the island province of Bali is argu-
ably of special interest for influenza surveillance and re-
search, due to a variety of cultural, ecological and
socio-economic factors that converge here to make it a
potential hotspot for the emergence and spread of influ-
enza viruses [11, 12]. For example, the predominance of
Hinduism in Bali, in contrast to the Muslim-majority
populations in many other parts of Indonesia, means
that pork production and consumption are relatively
high in Bali. The pig population in 2013 was estimated
at almost 1 million, the second highest among all Indo-
nesian provinces [13], with pigs often raised in rural
smallholders systems which also keep poultry. In
addition, with a geographic area of 5633 km2 and a hu-
man population of around 3.9 million, Bali has a high
human population density, and is also a major tourist
destination, hosting an estimated 9 million visitors in
year [14]. Together, the high densities of, and close inter-
actions between, human, pigs and poultry, along with
the high mobility of the human population, provide fer-
tile conditions for cross-species and human-to-human
transmission, and make the island a potential “mixing
bowl” for influenza viruses from a wide range of geo-
graphic regions.
Considering the convergence of these factors on
Bali, along with the high incidence and rapid muta-
tion rate of influenza viruses, continuous monitoring
of circulating influenza strains is extremely important.
This project aims to help rectify the lack of know-
ledge on influenza in Indonesia, by conducting four
years of influenza surveillance among humans pre-
senting with influenza-like illness at health facilities
across Bali. This study was initiated following the
emergence of influenza A/H1N1-pdm-09 in 2009 with
specific objectives to identify the influenza strains cir-
culating among humans in Bali, and describe their
epidemiological, clinical and virological characteristics.
Methods
Study design
Four years of active surveillance of influenza viruses
among patients presenting with influenza-like illness
(ILI) was conducted in Bali province, Indonesia, from
July 2010 until June 2014. Patients were recruited from
the outpatient departments of 21 sentinel health facil-
ities (10 government hospitals and 11 urban health cen-
ters) across all eight regencies and the provincial capital
city, Denpasar (in Indonesia, regencies and cities are
the second-level of administrative sub-division, between
province and district). ILI was defined as measured
fever of ≥38 °C at time of presentation, or self-reported
recent history of fever (in the last 10 days), and at least
one upper respiratory symptom. This is similar to the
current WHO recommended ILI case definition (“an
acute respiratory illness with a measured temperature
of ≥ 38°C and cough, with onset within the past 10
days”) [15], but not identical, since the latter was pub-
lished in 2011, after the surveillance period for our
study had begun. In addition to measured fever,
self-reported fever was included in our case definition,
based on observations by local health authorities that
patients with fever often self-administer analgesics such
as acetaminophen (which can reduce fever) prior to
seeking health care.
A systematic interval sampling approach [15] was
applied to ensure samples were obtained across all re-
gencies of the province throughout the year. Specific-
ally, every month each sentinel site was requested to
recruit at least the first two consenting patients pre-
senting with ILI, in order to achieve our target of
recruiting at least 2000 ILI patients in total over the
study period. Monthly intervals were chosen for sam-
pling quotas in order to give sufficient temporal reso-
lution to identify patterns in virus circulation, whilst
acknowledging that weekly sampling intervals would
overburden health facilities with limited capacities,
and also may not be feasible during periods of rela-
tively low ILI incidence. There was some variation in
actual monthly sampling rates between facilities, with
some unable to meet their quota of two patients
every month (for example due to low numbers of ILI
presentations, limited capacities, and turnover of des-
ignated staff ), while other facilities often exceeded
their quota. Despite this variation, the sampling de-
sign enabled us to meet our overall goal of recruiting
at least 2000 ILI patients throughout the study
period, with samples obtained from every regency of
Bali throughout the year.
Questionnaire administration and specimen collection
Written informed consent was obtained for all partici-
pants included in the study. For every patient meeting
the inclusion criteria, designated staff within the health
facility asked for their willingness to be involved in the
research. Afterwards, staff explained the purpose of this
research as shown in information sheet. If they agreed,
they were asked to sign the informed consent letter. For
participants under 18 years old, written informed con-
sent was obtained from their accompanying parent or
guardian.
Upon recruitment of ILI cases, a questionnaire was ad-
ministered by health staff to collect data on demographic
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variables, symptoms, any underlying medical conditions,
and potential exposure-related risk factors (including re-
cent contact patterns within humans and animals). In-
formation on any treatments prescribed to the patient
was also recorded. The questionnaire was developed fol-
lowing consultation with local health authorities and
health workers and was pilot-tested at health facilities
prior to implementation.
Nasopharyngeal swabs were obtained from enrolled
ILI patients, placed in viral transport medium, and re-
frigerated at 4 °C until they could be transported to the
laboratory at Udayana University in Denpasar. Samples
were transported to the laboratory within 48 h after col-
lection, where they aliquoted and stored at -70 °C until
processing. The mean duration between sample collec-
tion and testing was 18 days.
RNA extraction and qRT-PCR for influenza diagnosis and
subtyping
At the virology laboratory in Udayana University, all col-
lected swabs were subjected to a diagnostic assay to detect
and differentiate between influenza A and B using reverse
transcription-PCR (RT-PCR). RNA extraction was per-
formed using QIAmp viral RNA mini kit (Qiagen). Influ-
enza A positive samples were subjected to subtyping of
the haemaglutanin gene using single reactions, following
WHO recommended protocols [16]. Detailed procedures
can be found in the Supporting Information.
Data analysis
Data were double-entered and cleaned in an Excel data-
base, and statistical analyses were performed using R
version 3.3.2 (https://cran.r-project.org/). Descriptive
analyses were performed to investigate the distribution
of virus strains by age group, geographic area, and
month. Laboratory-confirmed influenza among ILI cases
was tested for associations with demographic, behavioral
and clinical variables in univariable analyses based on
Chi-squared tests, and multivariable analyses using logis-
tic regression. In these analyses, four influenza diagnos-
tic outcome variables were considered separately:
laboratory confirmed infection with any influenza virus,
and laboratory confirmed infection with each of the
three most common influenza types/subtypes (A/H3N2,
A/H1N1-pdm09, and B). Patient age group, sex, and any
variables found to be associated with any of the influenza
outcomes with P < 0.1 in univariable analyses were subse-
quently included as independent variables in the multivar-
iable logistic regression models. Hospitalization was also
examined as outcome variable to test for associations with
age, sex, pre-existing respiratory conditions, and influenza
diagnosis using a similar approach. Statistical significance
was assessed based on P < 0.05.
Results
Study participant characteristics
Over the 4-year study period, 2077 patients with ILI
symptoms were recruited in the study area. The mean
age of patients was 17.0 years old (range 0.5–80 yrs),
55.6% were male, and three quarters (75.4%) were re-
cruited at primary health centers, with the remainder re-
cruited at hospitals. In 2010, 162 (7.8%) patients were
sampled, followed by 641 (30.9%), 506 (24.4%), 520
(25.0%), and 248 (11.9%) in years 2011, 2012, 2013, and
2014 respectively. Based on location, a quarter (25.5%)
of study participants were recruited at the sentinel sites
in Denpasar, followed by Badung (16.7%), Tabanan
(14.5%), Klungkung (12.2%), Buleleng (11.2%), Jembrana
(9.3%), Bangli (4.1%), Karangasem (3.7%), and Gianyar
(2.8%).
Influenza diagnoses
Of all 2077 specimens tested using real time-PCR assays,
291 (14.0%) tested positive for influenza A, 152 (7.3%)
for influenza B, and sixteen (0.77%) tested positive for
both influenza A and B (Fig. 1a). Of the 307 influenza A
samples, 188 (61.2%) were subtyped as A/H3N2, 80
(26.1%) as A/H1N1-pdm09, and one (0.3%) as seasonal
A/H1N1 (Fig. 1b). Thirty-six (11.7%) of the influenza A
positive swabs tested negative in all subtyping assays,
and were therefore of undetermined subtype. This may
have been due to a low viral load in these samples,
resulting in the positive targeting of the M gene, but
negative detection of the HA gene in subtyping assays.
No co-infections with multiple influenza A subtypes
were detected. We also obtained samples from two sus-
pected avian influenza A/H5N1 cases (a sister and
brother aged 5 and 10 respectively; both fatal) in Octo-
ber 2011, which were confirmed as A/H5N1. It should
be noted, however, that these A/H5N1 cases were not
recruited through the systematic interval sampling of ILI
cases presenting at our sentinel facilities. Rather, these
two cases had been hospitalised at Sanglah Hospital with
suspected avian influenza, and specimens were purpos-
ively sampled and sent to Udayana laboratory for testing.
Spatial and temporal patterns
Patterns of influenza virus distribution were broadly
similar across geographic areas (Fig. 2). However, there
was significant variation by regency in the proportion of
ILI cases testing positive for influenza (χ2 = 37.7; df = 8;
p < 0.001), which ranged from 12.6% (Tabanan) to 27.6%
(Denpasar).
Influenza viruses were detected in every month through-
out the study period (Fig. 3), although influenza positive
rates among ILI specimens were significantly higher during
Bali’s wet season months (i.e., between October and April),
compared with the dry season (May–September) (28.3% vs
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13.8%; χ2 = 61.1; df = 1; p < 0.0001). The association with
wet season was stronger for influenza A subtypes compared
with influenza B (Fig. 3; Table S1 and Table 1).
Patterns of differential temporal circulation of virus
type/subtypes were evident, with each of the three
main circulating influenza viruses showing two or
three dominant phases throughout the study period.
Specifically, influenza B was predominantly detected
in Jul-Oct 2010, Feb-July 2012, and March, April &
August 2013, influenza A/H1N1-pdm09 in Nov
2010-Apr 2011 and August 2012-Feb 2013, and influ-
enza A/H3N2 in Jul 2011-Jan 2012, March and June
2013 (Fig. 3).
Clinical presentation
The prevalence of symptoms among ILI patients at time
of recruitment are shown in Fig. 4, and univariable and
multivariable analyses for associations with influenza test
results are presented in Additional file 1: Table S1 and
Table 1, respectively. Cough, rhinorrhea, and a measured
fever (≥38 °C at time of presentation) were the most
common symptoms, reported among 89.1, 70.0, and
69.0% of ILI patients, respectively. In univariate analysis,
onset of ILI symptoms during the wet season was signifi-
cantly associated with all influenza diagnostic outcomes.
In addition, patients with measured fever ≥38 °C were
significantly more likely to test positive for influenza
Fig. 1 Diagnostic test results of 2077 Patients with ILI Symptoms (a), and subtype distribution of influenza A samples (b)
Fig. 2 Spatial distribution of influenza viruses among patients presenting with influenza-like illness in Bali, Indonesia. The area of each pie chart is
proportional to the number of ILI patients sampled. The map in this figure was generated on our own
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(odds ratio [OR]: 1.41; 95% confidence interval [95% CI]:
1.1–1.8), and specifically influenza B (OR: 1.54; 95% CI:
1.05–2.26), while those with measured fever ≥39 °C were
more likely to test positive specifically for A/H1N1-pdm09
(OR: 1.93; 95% CI: 1.09–3.42). Rhinorrhea (OR: 1.65; 95% CI:
1.15–2.37) and chest pain (OR: 2.19; 95% CI: 1.15–4.18) were
significant clinical predictors of A/H3N2, while patients with
abdominal pain (OR: 0.36; 95% CI: 0.13–0.98) were less likely
to test positive for this virus (Additional file 1: Table S1).
Multivariable regression models, incorporating all symptom
variables that showed significant associations in univariate
analysis, and adjusting for age and sex, found symptom onset
in the wet season to be the strongest clinical predictor of la-
boratory confirmed influenza, and specifically influenza A
subtypes (adjusted OR for A/H3N2: 4.97; 95% CI: 3.24–
7.61). Measured fever was the strongest clinical predictor for
influenza B (adjusted OR: 1.62; 95% CI: 1.10–2.39), but was
no longer significant for other influenza outcomes in the
multivariable analysis (Table 1).
There was no significant association between influenza
positivity and the type of facility (hospital vs health
centre) at which ILI patients were sampled (Additional
file 1: Table S1). In terms of treatments, antibiotics and
antiviral drugs were prescribed to 71.3 and 2.2% of ILI
patients, respectively (noting that prescriptions were
made based on clinical assessment by the health worker,
before our influenza laboratory test results were avail-
able). The most commonly prescribed antiviral medica-
tion was oseltamivir, which accounted for 34 (73.9%) of
the 46 reported antiviral prescriptions. ILI cases who
tested positive for influenza A/H3N2 were significantly
more likely to have been prescribed antivirals (OR: 2.34;
95% CI: 1.15–4.75) (Additional file 1: Table S1).
Demographic and risk factor assessment
Results of regression analyses of demographic and other
risk factors for associations with influenza diagnosis are
given Table 2. The highest number of influenza cases
Fig. 3 Temporal patterns of influenza virus detection among ILI patients in Bali between July 2010 and June 2014
Table 1 Multivariable logistic regression analysis of clinical variables associated with laboratory confirmed influenza among ILI
patients in Bali
Any Influenza (A or B) Influenza A/H1N1-pdm09 Influenza A/H3N2 Influenza B
AOR (95% CI) P AOR (95% CI) P AOR (95% CI) P AOR (95% CI) P
ILI symptom onset in wet season 2.41 (1.90,3.04) < 0.001 3.46 (1.93,6.23) < 0.001 4.97 (3.24,7.61) < 0.001 1.37 (0.98,1.92) 0.07
Measured fever ≥38 °C 1.22 (0.95,1.57) 0.13 0.91 (0.53,1.57) 0.74 1.05 (0.73,1.52) 0.78 1.62 (1.10,2.39) 0.02
Measured fever ≥39 °C 1.29 (0.93,1.77) 0.12 1.79 (0.97,3.30) 0.06 1.53 (0.98,2.38) 0.06 0.59 (0.34,1.04) 0.07
Rhinorrhoea 1.24 (0.97,1.58) 0.09 0.78 (0.48,1.27) 0.33 1.72 (1.17,2.52) 0.01 1.01 (0.71,1.45) 0.95
Chest pain 1.43 (0.81,2.55) 0.22 0.70 (0.16,3.05) 0.64 2.49 (1.23,5.01) 0.01 0.70 (0.25,2.00) 0.51
Abdominal pain 0.81 (0.49,1.33) 0.41 1.30 (0.53,3.16) 0.57 0.35 (0.12,0.98) 0.05 1.10 (0.55,2.19) 0.79
AOR, adjusted Odds Ratio. (Values are adjusted for age, sex, and other clinical variables in the table)
CI, confidence interval
Data in bold are statistically significant
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was observed in age group 5–14, followed by age 0–4,
with 58.4% of all influenza positive samples originat-
ing from these age groups. This reflects the relatively
high number of ILI patients recruited from these
age-groups, rather than higher influenza positive rates
among children with ILI (Fig. 5). Relatively few (39)
patients aged ≥65 years were recruited, of which five
(12.8%) tested positive for influenza (Fig. 5a). The
proportion of ILI cases testing positive for any influ-
enza virus differed significantly between age groups
(χ2 = 17.6; df = 6; p = 0.007), and was highest in those
aged between 5 and 14 years (Fig. 5b). No significant
Fig. 4 Prevalence of symptoms among ILI patients in Bali (*denotes significant association with influenza test positivity at P < 0.05)
Table 2 Univariable and multivariable logistic regression analysis of demographic and behavioural variables for associations with
laboratory confirmed influenza among ILI patients in Bali
Univariable associations with influenza positivity Multivariable associations with influenza positivity
Crude OR (95% CI) P Adjusted OR (95% CI) P
Age group (y) (ref: 0–4)
5–14 1.59 (1.21,2.08) 0.007 1.48 (1.10,1.99) 0.04
15–24 1.54 (1.10,2.16) 1.35 (0.94,1.96)
25–34 1.59 (1.09,2.32) 1.47 (0.99,2.19)
35–44 1.32 (0.88,1.98) 1.20 (0.78,1.83)
45–64 1.10 (0.73,1.66) 0.84 (0.53,1.32)
65+ 0.63 (0.24,1.62) 0.64 (0.24,1.67)
Male sex 1.00 (0.81,1.23) 1 0.97 (0.78,1.20) 0.76
Pre-existing chronic respiratory condition 0.71 (0.33,1.52) 0.37 – –
Smoker 0.64 (0.25,1.68) 0.37 – –
No. of face to face contacts per day (ref: 0–4 persons)
10–49 1.39 (1.10,1.77) 0.002 1.19 (0.93,1.54) 0.18
50+ 1.77 (1.25,2.51) 1.41 (0.97,2.06)
Sick contact with ILI* 1.08 (0.77,1.50) 0.67 – –
Recent contact with poultryT 1.33 (1.04,1.70) 0.02 1.26 (0.89,1.78) 0.20
Recent contacts with pigsT 1.40 (1.05,1.88) 0.02 1.15 (0.86,1.54) 0.35
OR, Odds Ratio
CI, confidence interval
*Contact with another person with ILI within 14 days prior to symptom onset;
TPhysical contact with live, sick or dead animals within 14 days prior to symptom onset
Data in bold are statistically significant
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associations were found between influenza virus de-
tection and sex, smoking, or having a pre-existing
chronic respiratory condition (Table 2).
In terms of behavioural risk factors, ILI cases reporting
a higher estimated number of face-to-face human con-
tacts per day tended to be more likely to test positive for
influenza, although this was not significant when adjust-
ing for other variables (Table 2). Approximately 12% of
ILI cases reported contact with another person with ILI
symptoms within 14 days prior to their own symptom
onset; this was not significantly associated influenza
positivity. Frequency of variables related to poultry and
pig exposure were high among the study population,
with 54 and 25% of ILI patients living in households that
own poultry and pigs, respectively, and 20 and 12% of
patients reporting recent physical contact (within 14
days prior to symptom onset) with poultry and pigs, re-
spectively (Fig. 6). Furthermore, recent contact with
poultry and pigs were both significantly associated with
influenza infection in univariate analysis (OR: 1.33; 95%
CI: 1.04–1.70 and OR: 1.40; 95% CI: 1.05–1.88 respect-
ively), but not when adjusted for other variables in mul-
tivariable analysis (Table 2).
Hospitalizations
A total of 145 hospitalizations were reported among
1981 subjects for whom data on this were available, giv-
ing an overall ILI case hospitalization rate of 7.3%.
Hospitalization as an outcome variable was significantly
associated with age-group, pre-existing chronic condi-
tion, and influenza test results in both univariate and
multivariable analyses (Table 3). ILI cases testing positive
Fig. 5 Number of influenza positive samples (a), and influenza positive rates (b) among ILI patients in Bali by age-group
Fig. 6 Frequency of recent contact with humans with ILI, and contact and ownership of pigs and poultry, among patients with ILI in Bali
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for unsubtyped influenza A were more than three times
more likely to have been hospitalized compared with
influenza-negative ILI cases, when adjusting for age, sex,
and having a pre-existing chronic condition (adjusted
OR: 3.40; 95% CI: 1.28–9.30). Meanwhile, influenza B
cases were less likely to be hospitalized than
influenza-negative ILI cases, although this was less sig-
nificant in multivariable analysis. Being in the youngest
age group (0–4 yrs), and having a pre-existing chronic
respiratory condition were also significant risk factors
for hospitalization (Table 3).
Discussion
Over 4 years of influenza surveillance among ILI patients
in Bali between 2010 and 2014, this study found 22.1% of
patients with ILI were related with laboratory confirmed
influenza. This is generally within the range (~ 10–22%)
found across studies in other countries in Southeast Asia
[17–22], and highly consistent with national surveillance
data for Indonesia reported by the Ministry of Health
(MoH), in which influenza-positive rates among ILI pa-
tients ranged between 20 and 23% across years 2011–2014
[23–25]. Our Balinese data were also consistent with avail-
able nationwide data in terms of the relative frequencies at
which different influenza virus types and subtypes were
detected, with our data showing comparable positive rates
for influenza A (14.0%) and B (7.3%) to those reported by
MoH in 2014 (12.6 and 7.4%), and similar dominance of
influenza A/H3N2 during this period [25].
A strength of our study is the use of 21 sentinel health
facilities across all eight regencies and the provincial
capital city (Denpasar) in Bali, offering more compre-
hensive data for this province compared with the
national MoH surveillance data, which uses a single sen-
tinel site (a Public Health Center in Denpasar) in Bali.
Our results were generally comparable across different
regencies and types of health facility in Bali in terms of
the relative frequencies of influenza types/subtypes ob-
served, lending some support for the representativeness
of a single sentinel site Bali for the national MoH sur-
veillance system. Nevertheless, there was significant
variation in the overall influenza positive rate among
ILI cases, which ranged from 12.6% in Tabanan to
27.5% in Denpasar. The high rate in Denpasar might be
due to the higher density and/or mobility of the popu-
lation (given that Denpasar is a major tourist destin-
ation on the island) facilitating increased transmission
of influenza viruses to and within this area. However, it
is important to acknowledge that differences in influ-
enza positive rates among ILI patients may not reflect
differences in influenza attack rates, and could be
biased by heterogeneities in other factors, such as in
health seeking behavior, between regencies.
The year-round influenza activity we observed in Bali,
along with periods of peak activity coinciding with the wet
season, is typical of patterns previously observed in tropical
regions [26, 27], including Indonesia [24, 28]. Here we
found influenza A virus activity to be more strongly associ-
ated with the wet season than influenza B, and indeed onset
of symptoms during the wet season was the strongest pre-
dictor of influenza A infections among ILI patients. In
terms of clinical presentation, fever and cough are usually
Table 3 Univariable and multivariable logistic regression analyses of factors associated with hospitalization among ILI patients in Bali
Univariable association with hospitalization Multivariable association with hospitalization
Crude OR 95% CI P Adjusted OR 95% CI P
Age group (y) (ref: 0–4)
5–14 0.27 (0.17,0.44) < 0.0001 0.25 (0.15,0.41) < 0.0001
15–24 0.09 (0.03,0.26) 0.09 (0.03,0.24)
25–34 0.06 (0.02,0.25) 0.06 (0.01,0.24)
35–44 0.10 (0.03,0.33) 0.10 (0.03,0.34)
45–64 0.16 (0.06,0.40) 0.16 (0.06,0.39)
65+ 0.30 (0.07,1.26) 0.25 (0.06,1.11)
Male sex 1.41 (1.00,2.00) 0.05 1.30 (0.90,1.88) 0.17
Pre-existing chronic respiratory condition 4.34 (2.20,8.57) < 0.0001 5.55 (2.61,11.81) < 0.0001
Influenza diagnosis (ref: Negative)
B 0.35 (0.13,0.96) < 0.0001 0.45 (0.16,1.25) 0.0003
A/H3N2 0.61 (0.29,1.27) 0.68 (0.32,1.43)
A/H1N1-pdm09 1.28 (0.58,2.86) 1.71 (0.73,3.99)
A/Unsubtyped 2.50 (1.02,6.15) 3.4 (1.28,9.02)
OR, Odds Ratio. (Adjusted OR values are based on multivariable logistic regression adjusting for all other variables in the table);
CI, confidence interval
Data in bold are statistically significant
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considered the most relevant symptoms of influenza infec-
tion [29–31]. While we found that ILI patients with mea-
sured fever at presentation with cutoff point ≥38 °C were
more likely to have laboratory-confirmed influenza infec-
tion, and particularly influenza B, cough was not signifi-
cantly associated with influenza detection. In fact we found
rhinorrhea and chest pain to be more strongly associated
with influenza A/H3N2 (but not influenza A/H1N1-pdm09
or influenza B) compared with fever or cough.
Almost 60% of ILI cases and of laboratory-confirmed in-
fluenza cases in this study represented the pediatric popu-
lation (infants, children and adolescents up to 14 years
old), consistent with the higher clinical attack rates often
observed for influenza in these age groups [18, 25, 32, 33],
and indicating children to be more susceptible to, and the
main reservoir of, influenza viruses in this setting [34]. Al-
though again, given that ours was not a population-based
study design, differences in health seeking behavior could
also have a substantial impact on the age-distribution of
ILI and influenza cases that we observed. Influenza detec-
tion rates among ILI cases tended to be lower in the youn-
gest age group (0–4 years), which could reflect high
incidence of other ILI etiologies, such as respiratory syn-
cytial virus, in young children [22].
Previous studies suggest that age profiles for risk of in-
fluenza infection can be partly explained by social mix-
ing patterns, with mathematical models that are
parameterized using such data better able to capture ob-
served patterns of influenza spread, such as higher at-
tack rates among 5–19 year olds during the initial stages
of an epidemic [35, 36]. Here, we found that that influ-
enza positive ILI patients tended to have a higher num-
ber of self-reported average daily contacts, although this
association was not significant when adjusting for other
variables.
Our findings show high rates of ownership of, and phys-
ical contact with, both poultry and pigs among ILI cases
in Bali. Interestingly, recent physical contact with poultry
and pigs were both significantly associated with laboratory
confirmed influenza among ILI cases in univariate ana-
lysis. It should be emphasized that this result is unlikely to
reflect a causal relationship relating to zoonotically ac-
quired infections, given our focus on laboratory detection
of human influenza viruses (except for laboratory confirm-
ation of two suspected A/H5N1 cases), and the loss of
statistical significance when adjusting for other variables.
Nevertheless, these findings do further highlight the po-
tential for cross-species transmission of influenza viruses
in this setting, including reverse zoonotic transmission
from infected humans to animals which could increase
risk of re-assortment between human and animal viruses.
Genetic sequencing of viruses isolates is underway to in-
vestigate whether any of the infections may represent
reassortant or zoonotic strains.
Further molecular studies will also aim to characterize
the influenza A positive samples which could not be
subtyped using our standard PCR assays. It is not un-
common for influenza A positives of indeterminate sub-
type to be detected in influenza surveillance, which can
result from low viral loads in the nasopharyngeal sam-
ples, imperfect sensitivity of the subtyping assays, and
genetic drift at the target sites of the PCR primers.
Nonetheless, the significantly higher hospitalization rate
observed among ILI cases with unsubtyped influenza A
(but not those with confirmed A/H1N1-pdm09 or A/
H3N2 infection), at over three times the hospitalization
rate of influenza-negative cases, is interesting and war-
rants further investigation.
Conclusions
In conclusion, over four years of active sentinel surveil-
lance in Bali, Indonesia, between 2010 and 2014, 22% of
ILI cases were associated with laboratory confirmed in-
fluenza infection, with year-round influenza virus circu-
lation on the island and higher influenza activity during
the wet season. High rates of ownership and contact
with poultry and pigs were reported among ILI cases, in-
dicating the potential for cross-species influenza trans-
mission in this setting. Genetic characterisation and
molecular epidemiological studies are needed to gain in-
sights into the epidemiological and evolutionary dynam-
ics of influenza in Bali, and for early detection of novel
reassortant viruses.
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analysis to assess association between several clinical presentations and
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